- Home
- KYNB vs DRK Comparison
KYNB vs DRK Comparison
Compare KYNB & DRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$5.99
Company Overview
Basic Information| Metric | KYNB | DRK |
|---|---|---|
| Founded | 1993 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.8M | 26.9M |
| IPO Year | 2014 | 2020 |
Fundamental Metrics
Financial Performance| Metric | KYNB | DRK |
|---|---|---|
| Price | $5.99 | $2.77 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $39.67 | N/A |
| AVG Volume (30 Days) | 27.8K | ★ 208.8K |
| Earning Date | 11-09-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9552.08 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $6,440,000.00 | ★ $11,181,000.00 |
| Revenue This Year | $4.23 | $14.11 |
| Revenue Next Year | $14.15 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.62 | $2.50 |
| 52 Week High | $9.58 | $3.19 |
Technical Indicators
Market Signals| Indicator | KYNB | DRK |
|---|---|---|
| Relative Strength Index (RSI) | 21.99 | 38.95 |
| Support Level | N/A | $2.70 |
| Resistance Level | $7.41 | $3.19 |
| Average True Range (ATR) | 0.37 | 0.21 |
| MACD | -0.16 | -0.02 |
| Stochastic Oscillator | 14.38 | 39.13 |
Price Performance
Historical Comparison KYNB
DRK
About KYNB Kyntra Bio Inc. Common Stock
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.